New research on commonly prescribed blood thinners shows that rivaroxaban, known better by its brand name Xarelto, was associated with a significantly higher risk of bleeding complications. To provide much-needed transparency for patients, U-M researchers tested three popular medications prescribed to treat blood clots or atrial fibrillation. Read about their findings in this article from the Institute for Healthcare Policy and Innovation.
![Senior Patient Holding Nurse Hand 1](https://alumni.umich.edu/wp-content/uploads/senior-patient-holding-nurse-hand_1.jpg)